The structures ofantiviral antibiotics kistamicins A and B have been determined by a combination of chemical degradation and spectral analysis. They are commonly composed of D-tyrosine, 3,5-dihydrophenylglycine, a biphenyl ether bis-amino acid, and a diphenyl substituted indole tris-amino acid, forming a tricyclic ring structure. Kistamicin B possessed a phenethylamide at the amino terminal of kistamicin A. They are structurally related to the nuclei of the vancomycin group antibiotics particularly to antibiotic complestatin.
In spite of the considerable effort expended to date, only a few compoundshave been discovered from natural sources that are effective against viruses. In our screening programfor fermentation metabolites, we have discovered two new antiviral antibiotics, designated kistamicins A and B in the culture broth of Microtetraspora parvosata subsp. kistnae subsp. nov. collected in India. The taxonomy of the producing organism and the production, physico-chemical properties and biological activities of kistamicins A and B, have been reported in preceding paper1}. In this report we present the structural studies on these antibiotics.
Results and Discussion
Kistamicins A (1) and B (2) were isolated from the fermentation broth of Microtetraspora parvosata subsp. kistnae subsp. nov. by 1-butanol extraction followed by column chromatography on silica gel and reversed phase silica gel1}. They were obtained as pale yellow powders; 1, C61H51N8O15C1, mp >300°C (dec), MS5 -1.8°(c 1.0, MeOH); 2, C70H60N9O16Cl, mp >300°C (dec), [a]^5 +22°(c 0.5, MeOH).
The degradation and spectral studies for structure determination of kistamicins were first performed on 1. The UVspectrum of 1 exhibited absorption maxima at 231, 265, 284 and 305nmin MeOH, which moved to 244 and 286nm in alkaline solution. *H and 13C NMRspectra (Table 1) assisted with COSY experiments indicated the presence of seven aromatic and seven aliphatic units shown below.
Correspondence should be addressed to Jun Okumura, Britsol-Myers Squibb Research Institute, 2-9-3 Shimomeguro, Meguro-ku, Tokyo 153, Japan Acid hydrolysis (6m HC1, 110°C, 24hours) of1 gave three Ninhydrin positive, water-soluble products (3, 4 and 5) , and two of them were identified as D-tyrosine (3) and 3,5-dihydroxyphenylglycine (4)2) based on their physico-chemical and spectral data, and amino acid analysis results. The stereochemistry of4 was deduced to be "d" by a comparison of its specific optical rotational value ([a]J5 -85°, c 0.5, 1 m HC1) with those of D-4-hydroxyphenylglycine3) and d-3 , 5-dimethoxyphenylglycine4). Upon TV-acetylation in MeOHfollowed by methylation with diazomethane, 5 afforded the d\-Nacetyl-tri-O-methyl derivative (6), which showed a molecular ion peak at m/z 492 together with an isotope ion peak at m/z 494 indicating the presence of a chlorine in the molecule. Two phenyl rings were demonstrated by its XHand 13C NMRspectra. An ether linkage and substituents on these two rings of 6 were assigned based on the calculated 13C chemical shift values of the aromatic carbons and COLOC ex- periment (2/c-h and/or 3/c_H of the quaternary carbons). The structure was further confirmed by NOESY experiment on di-O-demethyl-6 (7) which was obtained by mild saponification of 6. Clear NOEswere observed between 4-methoxy protons (3 3.70 ) and the ortho (3 7.01, 3-H) and meta (S 7.14, 2-H) protons.
In order to isolate the remaining portion of 1, which was presumedto contain an indole nucleus by the NMRstudies, 1 was hydrolyzed with 6m HC1 containing thioglycolic acid at 110°C for 24hours5). From the hydrolysate, a new amino acid (8) positive to Ehrlich's reagent was isolated along with 3, 4 and 5. The struture of 8 was assigned by its 1H and 13C NMRspectra as shown above.
Linkage of these four amino acids (3, 4, 5 and 8) by six peptide bonds accounts for the molecular formula of 1. The linkages were established by the HETCORand long range HETCOR(8 Hz) experiments of 1. In addition, the NOEcorrelations between the protons of these amino acids, particularly those between a-methines and/or amide protons were analyzed as shownin Fig. 2 assigning the total structure of 1. The location of the tyrosine at N-terminal was confirmed by Edmandegradation of 1. After first cycle of degradation, 1 gave PTH-tyrosine together with hexapeptide (9). The aromatic ring system of the upper half of 1 (amino acid 8) was also confirmed by 13C chemical shifts comparison with that of complestatin3), a protease inhibitor of complement in the humancomplement system6). The corresponding 13C signals of amino acid 8 moiety in 1 and complestatin agreed well with each other except the presence of an additional TV-methyl signal in the latter. Thus the structure of1 was determined as shown in Fig. 1 .
The physico-chemical properties and *H and 13C NMRspectra of 2 (Table 1) are very similar to those of 1. The NMRspectra and molecular formula of 2 indicated the presence of an additional set of signals which were assignable to a 2-phenethylaminocarbonyl residue. The presence of this group was confirmed by recovery of 2-phenethylamine (10, EI-MS m/z 121, M+) upon total acid hydrolysis of 2. In the NOESY of 2, the proton signals of the 2-phenethylamino moiety did not show NOEswith any protons of other constituents suggesting that this group was a terminal unit of the molecule. As stated before, degradation of 1 gave a PTH-tyrosine together with 9, on the other hand 2 was unreactive to the reaction. These data indicated that 2-phenethylamine was substituted via an ureide bond at the 7V-terminu& in 2 as shown in Fig. 1 .
Kistamicins A and B are structurally related to the glycopeptide antibiotics such as vancomycin, ristocetin and teicoplanin. Kistamicins A and B are however distinct in possessing an indole nucleus in place of the modified tyrosine or /Mrydroxytyrosine contained in the latter group of antibiotics. Kistamicins DEC. 1993 A and B are closely related to antibiotic complestatin6). It is interesting to note that 9 which lacks only the TV-terminal tyrosine residue to 1 was completely inactive against the influenza virus in our test. The vancomycin aglycone prepared by the method of Nagarajan and Schabel7) also did not show activity against the virus in our assay.
Experimental
General Procedure TLC was performed on precoated silica gel plates (Silica gel 60 F254, Merck, 0.25 mmthick). The IR spectra were determined on a Jasco IR-810 spectrometer and the UVspectra on a Jasco UVIDEC-G10C spectrometer. The XHand 1 3C NMRspectra were recorded on a JEOL JNM-GX400spectrometer operated in the Fourier transform mode using tetramethylsilane and/or dioxane as the internal standard. EI-MS and FAB-MSwere run with a JEOL JMS-DX3O3HFspectrometer. Optical rotation was determined with a Jasco Model DIP-140. Aminoacid analysis was carried out on a PICO TAGamino acid analysis system (Waters).
Total Acid Hydrolysis of 1 Kistamicin A (1, 520mg) was heated in 6m HC1 (30ml) at 110°C for 24hours in a sealed container. The hydrolysate was dried in vacuo and the residue was dissolved in water and applied on a column of Dowex 50Wx 8 (H+) which was developed with dil. HC1. The eluate was monitored by TLC and the fractions containing homogeneous amino acids were pooled and concentrated. 4 (73 mg) was eluted with 0.6m HC1, 3 (90mg) with 1m HC1 and 5 (96mg) with 6.5m HC1. Di-7V-acetyl-tri-0-methyl-5
5 (6mg) was dissolved in MeOH(1 ml) and acetylated with acetic anhydride (0.2ml) at room temperature for one hour, and the reaction solution was evaporated in vacuo. The residue was treated with an excess CH2N2in ether. The usual work-up followed by purification of the product by preparative TLC developing with toluene-MeOH (4: 1) yielded pure 6 (3.7mg): mp 77~79°C; HREI-MS m/z 492.1316 (M+), Zll.6mmu for C23H25N2O8C1; IRvmax (KBr) 1745, 1660, 1510, 1490, 1275, 1240cm-1 Di-7V-acetyl-mono-0-methyl-5
6 (3 mg) was dissolved in 0.1 m KOH-MeOH(2ml) and refluxed for 30minutes. The reaction solution was diluted with water (10ml), acidified to pH 3.0 and then extracted with EtOAc (5 ml). Purification of the extract by preparative TLC with CHC13-MeOH-AcOH(14 : 6 : 1) followed by Sephadex LH-20 column chromatography (MeOH) afforded 7 (1.6mg): mp >280°C (dec); HRFAB-MS m/z 465.1066 (M+H)+,
